![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: D'Amato M. Rovati L.C.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.6, Iss.7, 1997-07, pp. : 819-836
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders
By Mally J.
CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mixed results with endothelin receptor antagonists in cardiovascular disorders
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :